1,763 results on '"Fudim, Marat"'
Search Results
2. Ongoing and Future Clinical Trials of Pharmacotherapy for Heart Failure
3. Prognostic value of quality of life and functional status in patients with heart failure: a systematic review and meta-analysis
4. The role of urine chloride in acute heart failure
5. Author Correction: Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure
6. Spot urine sodium as a marker of urine dilution and decongestive abilities in acute heart failure
7. Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis
8. Novel Trial Designs in Heart Failure: Using Digital Health Tools to Increase Pragmatism
9. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
10. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association
11. Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry.
12. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort
13. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
14. Feasibility of a Novel Augmented 6-Minute Incremental Step Test: A Simplified Cardiorespiratory Fitness Assessment Tool
15. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
16. Contemporary Decongestion Strategies in Patients Hospitalized for Heart Failure: A National Community-Based Cohort Study
17. Lower Extremity Lymphatic Flow/Drainage Assessment by Indocyanine Green Fluorescent Lymphography in Heart Failure Patients
18. Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum
19. Prevalence and Predictors of Readmissions in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation/Flutter
20. Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial
21. Blood Pressure Response and Symptoms During Active Standing Test Among Hospitalized and Outpatients With Heart Failure: Results From the GRAVITY-HF Prospective Observational Cohort Study
22. Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?
23. An international multidisciplinary consensus statement on MAFLD and the risk of CVD
24. Efficacy and Safety of Patiromer for Chronic Hyperkalemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
25. Ongoing and future clinical trials of device therapies for patients with heart failure
26. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF
27. Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases
28. Relationship between sex, body size, and cardiac resynchronization therapy benefit: A patient-level meta-analysis of randomized controlled trials
29. Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure
30. Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction – a secondary analysis of TOPCAT
31. Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review
32. A Multicenter Study of Stellate Ganglion Block as a Temporizing Treatment for Refractory Ventricular Arrhythmias
33. Prospective association of occupational and leisure-time physical activity with orthostatic blood pressure changes in older adults
34. Family income and cardiovascular disease risk in American adults
35. Endpoints for Clinical Effects of Renal Denervation: What Is the Best Surrogate?
36. Role of the Renal Lymphatic System in Heart Failure
37. Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement
38. Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure
39. A pilot study of longitudinal changes in neurocognition, white matter hyperintensities, and cortical thickness in atrial fibrillation patients following catheter ablation vs medical management
40. Association of Sacubitril/Valsartan vs Valsartan With Blood Pressure Changes and Symptomatic Hypotension: the PARAGLIDE-HF Trial
41. Patient Sex Impacts Volume Phenotypes and Hemodynamics in Chronic Heart Failure: A Multicenter Analysis
42. The impact of atrial fibrillation on clinical outcomes in heart failure with mid-range and preserved ejection fraction patients
43. Remote Follow-up in a Heart Failure Pragmatic Trial: Insights From the CONNECT-HF
44. Emerging devices for heart failure management
45. The spectrum of post-myocardial infarction care: From acute ischemia to heart failure
46. Relationship of Vascular Endothelial Growth Factor C, a Lymphangiogenesis Modulator, With Edema Formation, Congestion and Outcomes in Acute Heart Failure
47. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
48. Role of Lymphatics in Heart Failure
49. Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 1
50. Patient Selection and End Point Definitions for Decongestion Studies in Acute Decompensated Heart Failure: Part 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.